ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 102 filers reported holding ARATANA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $21,248 | -79.7% | 4,118 | -75.8% | 0.00% | -100.0% |
Q4 2018 | $104,455 | +5.0% | 17,040 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $99,514 | +1321.6% | 17,040 | +1104.2% | 0.00% | – |
Q4 2017 | $7,000 | -96.2% | 1,415 | -95.3% | 0.00% | -100.0% |
Q3 2017 | $186,000 | -15.5% | 30,359 | -0.3% | 0.00% | -50.0% |
Q2 2017 | $220,000 | +61.8% | 30,449 | +18.9% | 0.00% | +100.0% |
Q1 2017 | $136,000 | -12.8% | 25,619 | +17.9% | 0.00% | 0.0% |
Q4 2016 | $156,000 | -26.8% | 21,736 | -4.4% | 0.00% | -50.0% |
Q3 2016 | $213,000 | +31.5% | 22,738 | -11.6% | 0.00% | +100.0% |
Q2 2016 | $162,000 | -7.4% | 25,709 | +24.3% | 0.00% | 0.0% |
Q3 2015 | $175,000 | -42.6% | 20,686 | +2.6% | 0.00% | -50.0% |
Q2 2015 | $305,000 | -3.8% | 20,168 | +1.8% | 0.00% | 0.0% |
Q1 2015 | $317,000 | -19.5% | 19,810 | -10.5% | 0.00% | -33.3% |
Q4 2014 | $394,000 | +100.0% | 22,138 | +12.8% | 0.00% | +200.0% |
Q3 2014 | $197,000 | -35.6% | 19,624 | 0.0% | 0.00% | -50.0% |
Q2 2014 | $306,000 | – | 19,624 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Engaged Capital LLC | 3,487,149 | $21,376,000 | 3.96% |
Broadfin Capital, LLC | 4,083,135 | $25,030,000 | 3.29% |
MPM ASSET MANAGEMENT LLC | 250,000 | $1,533,000 | 1.30% |
GENERAL AMERICAN INVESTORS CO INC | 1,599,365 | $9,804,000 | 1.03% |
Grandeur Peak Global Advisors, LLC | 821,038 | $5,033,000 | 0.65% |
CADENCE CAPITAL MANAGEMENT LLC | 307,294 | $1,884,000 | 0.19% |
Redmond Asset Management, LLC | 60,176 | $369,000 | 0.18% |
Alambic Investment Management, L.P. | 65,000 | $398,000 | 0.17% |
MENTA CAPITAL LLC | 39,562 | $243,000 | 0.09% |
Campbell & CO Investment Adviser LLC | 12,990 | $88,000 | 0.09% |